期刊文献+

丙戊酸钠缓释制剂治疗小儿癫癎78例

Sodium Valproate in the Treatment of 78 Cases of Childhood Epilepsy
下载PDF
导出
摘要 目的 :观察丙戊酸钠缓释制剂 (德巴金 )治疗小儿癫的临床疗效。方法 :根据不同年龄选择丙戊酸钠缓释片 /糖浆治疗 78例癫患儿 ,并密切观察其发作控制的程度 ,嘱定期复查肝功能及血常规。结果 :完全控制 5 8例(74.4% ) ,显效 10例 (12 .8% ) ,有效 5例 (6.4% ) ,无效及效差 5例 (6.4% ) ,总有效率 93 .6%。结论 :丙戊酸钠缓释制剂是一种新型广谱抗癫药 ,使用方便 ,疗效显著 ,无明显的不良反应 。 Objective: To observe the clinical effect of depakine (sodium valproate) in the treatment of childhood epilepsy. Methods:78 epileptic children were treated with either godilum valproate sustained-release tablets or syrups according to their ages, the control degree of the seizures were observed and reexamination of liver function and blood routine were carried at periodically. Results: Of the 78 cases, 58 cases (74.4 percent) were completely controlled, 10 cases (12.8 percent) significantly improved, 5 cases (6.4 percent) improved, 5 cases (6.4 percent) remained the same. The total effective rate was 93.6 percent. Conclusion: Depakine is a new broad-spectrum, easily used anti-epliepsy drug. Its efficacy is significant and there are different dosage forms to be selected and no significant adverse reactions. So depakine is the first selection in treating childhood epilepsy and suited for clinical application.
出处 《医药导报》 CAS 2001年第5期296-296,共1页 Herald of Medicine
关键词 丙戊酸钠缓释制剂 癫痫 儿童 治疗 疗效 Sodium Valproate Epilepsy/Childhood Observation of the clinical effect
  • 相关文献

参考文献3

二级参考文献1

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部